Lilly Launches Free AI Platform for Biotech Drug Discovery
Eli Lilly has launched Lilly TuneLab, an AI/ML platform offering biotech companies access to proprietary drug discovery models trained on over $1 billion of Lilly's research data, aiming to accelerate innovation and support early-stage drug development through a privacy-preserving federated learning approach.